Tech Company Financing Transactions
Dash Bio Funding Round
Dash Bio, operating out of Boston, scored $6.5 million in investment from Freestyle Capital, Life Extension Ventures and Swift Ventures.
Transaction Overview
Company Name
Announced On
10/24/2024
Transaction Type
Venture Equity
Amount
$6,500,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to expand operations and its development efforts.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
56 Broad St. 14011
Boston, MA 02109
USA
Boston, MA 02109
USA
Phone
Undisclosed
Website
Email Address
Overview
While drug discovery is advancing exponentially, drug development is utterly outdated. Until now. Biotech has never been more innovative. mRNA technology has changed how we make vaccines, CRISPR is rewriting the genome, and there are hundreds of AI drug discovery startups promising to fundamentally transform how we discover new potential medicines.Yet despite this immense innovation, drug development remains stuck in the past.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Dave Johnson
Chief Operating Officer
Ander Tallett
Chief Scientific Officer
Ely Porter
Browse more venture capital transactions:
Prev: 10/24/2024: Finix Payments venture capital transaction
Next: 10/24/2024: Planetary Technologies venture capital transaction
Share this article
News on VC Transactions
We do our best to document every notable VC transaction. VC investment data records on this site come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs